Moving Towards PDE6A Gene Supplementation Therapy

JAMA Ophthalmol. 2020 Dec 1;138(12):1251-1252. doi: 10.1001/jamaophthalmol.2020.4216.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 6 / genetics
  • Dietary Supplements
  • Eye Proteins / genetics
  • Humans
  • Phenotype
  • Retinitis Pigmentosa*

Substances

  • Eye Proteins
  • Cyclic Nucleotide Phosphodiesterases, Type 6
  • PDE6A protein, human